An observational post-approval safety study of golimumab in treatment of polyarticular Juvenile Idiopathic Arthritis (pJIA) using the German Biologics JIA Registry (BiKeR) First published 30/01/2018 Last updated 09/10/2025 EU PAS number:EUPAS20781 Study Ongoing